Showing results (21-30 of 348) with videos related to

Sort By:
Pageof 35
Journal of Alzheimer'S Disease : JAD|April 5, 2014
Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activityMaria-Letizia Campanari, María-Salud García-Ayllón, Olivia Belbin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2025
Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndromeAurélie Ledreux, Maria Carmona-Iragui, Laura Videla, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2018
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platformConstance Delaby, Laia Muñoz, Soraya Torres, et al.
Translational Neurodegeneration|September 27, 2021
Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's diseaseNeus Barranco, Virginia Plá, Daniel Alcolea, et al.
Journal of Neuropathology and Experimental Neurology|November 15, 2013
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodiesMartí Colom-Cadena, Ellen Gelpi, Sara Charif, et al.
Archives of Neurology|November 16, 2002
Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in SpainAlberto Lleó, Rafael Blesa, Rosa Queralt, et al.
Sleep|April 5, 2019
Clinical and video-polysomnographic analysis of rapid eye movement sleep behavior disorder and other sleep disturbances in dementia with Lewy bodiesAna Fernández-Arcos, Estrella Morenas-Rodríguez, Joan Santamaria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMitchell Marta Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Neurobiology of Aging|July 24, 2012
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodiesMartí Colom-Cadena, Ellen Gelpi, María J Martí, et al.
Alzheimer'S Research & Therapy|October 29, 2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuumJulie Goossens, Alba Cervantes González, Nele Dewit, et al.
Pageof 35